Similar articles

• Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis.

  Stern RS, Thibodeau LA, Kleinerman RA, Parrish JA, Fitzpatrick TB. Stern RS, et al. N Engl J Med. 1979 Apr 12;300(15):809-13. doi: 10.1056/NEJM197904123001501. N Engl J Med. 1979. PMID: 423919
• [Treatment of psoriasis with UV-light, tar and psoralens].

  Fischer T, Juhlin L. Fischer T, et al. Lakartidningen. 1975 Nov 12;72(46):4511-4. Lakartidningen. 1975. PMID: 1195911 Swedish. No abstract available.
• Comparison of crude coal tar and topical methoxsalen in treatment of psoriasis.

  Petrozzi JW, Barton JO. Petrozzi JW, et al. Arch Dermatol. 1979 Sep;115(9):1061-3. Arch Dermatol. 1979. PMID: 485182
• Oral methoxsalen photochemotherapy of psoriasis and mycosis fungoides.

  Parrish JA, LeVine MJ, Fitzpatrick TB. Parrish JA, et al. Int J Dermatol. 1980 Sep;19(7):379-86. doi: 10.1111/j.1365-4362.1980.tb03732.x. Int J Dermatol. 1980. PMID: 6998879 Review. No abstract available.
• Long-term risks of psoralen and UV-A therapy for psoriasis.

  Farber EM, Abel EA, Cox AJ. Farber EM, et al. Arch Dermatol. 1983 May;119(5):426-31. Arch Dermatol. 1983. PMID: 6342539 Review.